Consolidated Balance Sheets (Current Period Unaudited) - USD ($) $ in Thousands	Mar. 31, 2019	Dec. 31, 2018
Assets
Unrestricted cash and cash equivalents	$ 101,049	$ 60,968
Restricted cash and cash equivalents	65,184	80,786
Loans, interest and fees receivable:
Loans, interest and fees receivable, at fair value	5,394	6,306
Loans, interest and fees receivable, gross	562,472	541,344
Allowances for uncollectible loans, interest and fees receivable	(85,319)	(79,211)
Deferred revenue	(47,251)	(43,897)
Net loans, interest and fees receivable	435,296	424,542
Property at cost, net of depreciation	3,385	3,625
Investments in equity-method investees	2,260	2,476
Deposits	125	124
Operating lease right-of-use assets	17,013
Prepaid expenses and other assets	11,922	10,087
Total assets	636,234	582,608
Liabilities
Accounts payable and accrued expenses	108,837	105,765
Total, net	27,742
Notes payable, at face value	408,242	390,927
Notes payable to related parties	40,000	40,000
Notes payable associated with structured financings, at fair value (associated with variable interest entities)	4,776	5,651
Convertible senior notes	62,313	62,142
Income tax liability	300	252
Total liabilities	652,210	604,737
Commitments and contingencies (Note 10)
Equity
Common stock, no par value, 150,000,000 shares authorized: 15,977,130 shares issued and outstanding (including 1,459,233 loaned shares to be returned) at March 31, 2019; and 15,563,574 shares issued and outstanding (including 1,459,233 loaned shares to be returned) at December 31, 2018
Paid-in capital	214,891	213,435
Accumulated other comprehensive income	2,045	3,558
Retained deficit	(232,516)	(238,784)
Total shareholders’ deficit	(15,580)	(21,791)
Noncontrolling interests	(396)	(338)
Total deficit	(15,976)	(22,129)
Total liabilities and deficit	$ 636,234	$ 582,608